Clinical Applications of Next Generation Sequencing
Next Generation Sequencing Part 2
Technological improvements in instrumentation and methodologies for next generation sequencing have changed the landscape of diagnosis and monitoring of disease. Mayo Clinic has implemented the first next generation sequencing test for identification of hereditary colorectal cancer with several other projects in development. Knowledge of an individual’s genome sequence provides information on life, health, risk factors, and also pharmacogenomic data to influence clinical decisions.
- David I. Smith, PhD
- Division of Experimental Pathology and Laboratory Medicine at Mayo Clinic in Rochester, Minnesota
The Next Generation Sequencing Revolution Series
Forward to a Colleague
Share this presentation with:
- Laboratory Technologists
- Genetic Counselors
If you have questions, e-mail .